AVNS
AVANOS MEDICAL, INC.Company Information
- Company Name
- AVANOS MEDICAL, INC.
- CIK
- CIK0001606498
- Category
- Large accelerated filer
- Ticker: Exchange
- AVNS: NYSE
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3842
- SIC Description
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- Ticker
- AVNS
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-08-13
- Last sale
- 2025-11-18
- Shares purchased (TTM)
- 20,000
- Shares sold (TTM)
- 22,000
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 42,908,727
- Shares outstanding
- 46,500,000
- Ownership
- 92.28%
Earnings Market Reaction
- Filing date
- 2026-05-05
- Price on filing date
- —
- 1-month reaction
- 0.40%
- 3-month reaction
- 1.17%
Balance Sheet
Values in millions ($)| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 66 | 90 | 71 | 90 | 97 | 108 | 89 | 92 | 76 | 88 | 107 | 82 | ||||||
| Accounts Receivable Net | 103 | 104 | 112 | 110 | 105 | 133 | 132 | 123 | 131 | 143 | 145 | 152 | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 325 | 355 | 351 | 356 | 352 | 393 | 473 | 474 | 468 | 487 | 525 | 507 | ||||||
| Inventory Net | 141 | 148 | 151 | 143 | 138 | 139 | 162 | 164 | 166 | 163 | 157 | 148 | ||||||
| Prepaid Expense And Other Assets Current | 15 | 14 | 19 | 13 | 13 | 14 | 16 | 22 | 29 | 29 | 14 | 16 | ||||||
| Assets Of Disposal Group Including Discontinued Operation Current | - | - | - | - | - | 0 | 74 | 73 | 67 | 65 | 102 | 109 | ||||||
| Property Plant And Equipment Net | 111 | 113 | 115 | 114 | 110 | 111 | 110 | 111 | 116 | 117 | 117 | 123 | ||||||
| Operating Lease Right Of Use Asset | 39 | 28 | 30 | 31 | 32 | 34 | 27 | 29 | 24 | 27 | 27 | 29 | ||||||
| Goodwill | 394 | 395 | 394 | 381 | 456 | 456 | 795 | 794 | 795 | 796 | 792 | 763 | ||||||
| Intangible Assets Net Excluding Goodwill | 115 | 118 | 122 | 105 | 107 | 112 | 220 | 226 | 233 | 240 | 242 | 223 | ||||||
| Deferred Income Tax Assets Net | 33 | 33 | 25 | 25 | 25 | 25 | 7 | 6 | 6 | 7 | 4 | 4 | ||||||
| Other Assets Noncurrent | 33 | 32 | 29 | 26 | 25 | 23 | 26 | 17 | 19 | 19 | 18 | 19 | ||||||
| Disposal Group Including Discontinued Operation Assets Noncurrent | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Assets | 1,050 | 1,074 | 1,068 | 1,039 | 1,108 | 1,154 | 1,656 | 1,658 | 1,661 | 1,692 | 1,725 | 1,667 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Long Term Debt Current | 11 | 10 | 9 | 9 | 9 | 9 | 9 | 10 | 9 | 9 | 6 | 6 | ||||||
| Operating Lease Liability Current | 10 | 8 | 10 | 10 | 10 | 11 | 14 | 14 | 12 | 13 | 13 | 14 | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 131 | 165 | 148 | 135 | 137 | 166 | 213 | 208 | 205 | 235 | 171 | 161 | ||||||
| Accounts Payable Current | 52 | 56 | 54 | 49 | 46 | 54 | 54 | 51 | 57 | 56 | 52 | 65 | ||||||
| Accrued Liabilities Current | 58 | 91 | 75 | 66 | 71 | 91 | 83 | 80 | 75 | 93 | 97 | 73 | ||||||
| Liabilities Of Disposal Group Including Discontinued Operation Current | - | - | - | - | - | 0 | 53 | 53 | 52 | 64 | 3 | 3 | ||||||
| Long Term Debt | 87 | 90 | 93 | 96 | 98 | 125 | 153 | 165 | 167 | 159 | 258 | 203 | ||||||
| Operating Lease Liability Noncurrent | 30 | 20 | 21 | 22 | 23 | 25 | 27 | 29 | 27 | 28 | 30 | 31 | ||||||
| Deferred Income Tax Liabilities Net | 6 | 6 | 6 | 6 | 6 | 6 | 24 | 23 | 24 | 24 | 29 | 22 | ||||||
| Other Liabilities Noncurrent | 14 | 14 | 21 | 4 | 5 | 4 | 11 | 11 | 11 | 10 | 16 | 15 | ||||||
| Liabilities Of Disposal Group Including Discontinued Operation Noncurrent | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Liabilities | 268 | 296 | 290 | 263 | 268 | 326 | 427 | 436 | 433 | 456 | 503 | 432 | ||||||
Stockholders Equity Including Portion Attributable To Noncontrolling Interest | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Additional Paid In Capital | 1,696 | 1,692 | 1,691 | 1,687 | 1,683 | 1,679 | 1,675 | 1,672 | 1,668 | 1,664 | 1,660 | 1,655 | ||||||
Stockholders Equity | ||||||||||||||||||
| Stockholders Equity | 782 | 778 | 778 | 776 | 839 | 829 | 1,230 | 1,222 | 1,228 | 1,236 | 1,222 | 1,235 | ||||||
| Retained Earnings Accumulated Deficit | -775 | -780 | -779 | -777 | -700 | -707 | -310 | -314 | -316 | -315 | -325 | -322 | ||||||
| Treasury Stock Common Value | -104 | -102 | -102 | -102 | -101 | -99 | -99 | -99 | -95 | -86 | -80 | -71 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -36 | -32 | -33 | -32 | -42 | -45 | -37 | -38 | -30 | -27 | -33 | -28 | ||||||
| Liabilities And Stockholders Equity | 1,050 | 1,074 | 1,068 | 1,039 | 1,108 | 1,154 | 1,656 | 1,658 | 1,661 | 1,692 | 1,725 | 1,667 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Preferred Stock Shares Authorized | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Common Stock Shares Authorized | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | ||||||
| Shares Outstanding | 47 | 46 | 46 | 46 | 46 | 46 | 46 | 46 | 46 | 46 | 46 | 47 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialAVANOS MEDICAL, INC. (AVNS) — SEC Financial Statements & Analysis
AVANOS MEDICAL, INC. (AVNS) is a orthopedic, prosthetic & surgical appliances & supplies company, incorporated in DE. AVANOS MEDICAL, INC. trades on NYSE as: AVNS. AVANOS MEDICAL, INC. (AVNS)'s most recent SEC filing is a Form 10-Q for the period ended 2026-03-31, filed with the SEC on 2026-05-05. Based on that filing, On profitability, AVANOS MEDICAL, INC. posts a gross margin of 50.05%, an operating margin of -8.80%, a net margin of -10.39%, a Return on Equity (ROE) of -9.18%, a Return on Assets (ROA) of -6.90%, and a Return on Invested Capital (ROIC) of -7.53%. Per share, it reports EPS of $-1.60, diluted EPS of $-1.57, free cash flow per share of $0.16, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 3.87% year-over-year, net income growth of -80.66% year-over-year, and EPS growth of -80.82% year-over-year. On the balance sheet, it maintains a current ratio of 2.48x, a quick ratio of 1.29x, working capital of $193.80M, a debt-to-equity ratio of 0.34x, a debt ratio of 0.26, an interest coverage ratio of -8.75x, free cash flow of $7.50M (TTM), and net debt of $21.70M. Figures sourced from SEC EDGAR.
- EPS TTM
- $-1.60
- ROE TTM
- -9.18%
- ROA TTM
- -6.90%
- Debt To Equity
- 0.34x
- Free Cash Flow TTM
- $7.50M
- Net Revenue TTM Growth 1Y
- 3.87%
Data as of 2026-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is AVANOS MEDICAL, INC. in?
AVANOS MEDICAL, INC. (AVNS) operates in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry.
What exchange does AVNS trade on?
AVANOS MEDICAL, INC. (AVNS) trades on the NYSE.
Where is AVANOS MEDICAL, INC. incorporated?
AVANOS MEDICAL, INC. is incorporated in DE.
When was AVANOS MEDICAL, INC. (AVNS)'s most recent SEC filing?
AVANOS MEDICAL, INC. (AVNS)'s most recent SEC filing is a Form 10-Q for the period ended 2026-03-31, filed with the SEC on 2026-05-05.
What is AVNS's EPS (earnings per share)?
AVANOS MEDICAL, INC. (AVNS)'s trailing twelve month EPS is $-1.60 as of 2026-03-31.
What is AVNS's ROE (return on equity)?
AVANOS MEDICAL, INC. (AVNS)'s trailing twelve month Return on Equity (ROE) is -9.18% as of 2026-03-31.
What is AVNS's ROA (return on assets)?
AVANOS MEDICAL, INC. (AVNS)'s trailing twelve month Return on Assets (ROA) is -6.90% as of 2026-03-31.
What is AVNS's ROIC (return on invested capital)?
AVANOS MEDICAL, INC. (AVNS)'s trailing twelve month Return on Invested Capital (ROIC) is -7.53% as of 2026-03-31.